Journal of Commercial Biotechnology is now archived and no
longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.
Volume 11, issue 1, October 2004
10 articles in this issue
-
-
Bioentrepreneurship in Japan: Institutional transformation and the growth of bioventures
Authors
- Michael J Lynskey
- Content type: Paper
- Published: 01 October 2004
- Pages: 9 - 37
-
Changes to the European Union pharmaceutical legislation: Implications of the ‘Pharma Review’ for biotechnology companies
Authors
- Erkki Liikanen
- Content type: Paper
- Published: 01 October 2004
- Pages: 38 - 43
-
A brave new Europe with the introduction of the EU Clinical Trials Directive: Impact upon the pharma industry and academic research with special emphasis on pharmacovigilance
Authors
- Graeme Ladds
- Content type: Paper
- Published: 01 October 2004
- Pages: 44 - 53
-
Interference basics
Authors
- Thomas J Kowalski
- William F Lawrence
- Samuel H Megerditchian
- Content type: Paper
- Published: 01 October 2004
- Pages: 54 - 62
-
Where will industry go to for its high-calibre staff?
Authors
- Faiz Kermani
- Rebecca Gittins
- Content type: Paper
- Published: 01 October 2004
- Pages: 63 - 71
-
Cross-border transactions: A roadmap for commercial arrangements between North American and European companies
Authors
- Raymond S Fersko
- Hind Merabet
- Valentina Cordioli
- Content type: Paper
- Published: 01 October 2004
- Pages: 72 - 79
-
Biotech blockbuster forecasts to 2008
Authors
- Alex K Pavlou
- Mark Belsey
- Content type: Paper
- Published: 01 October 2004
- Pages: 80 - 86
-
Regulatory data protection for medicines
Authors
- John Wilkinson
- Frederick J Dorey
- Content type: Miscellaneous
- Published: 01 October 2004
- Pages: 87 - 96
-
Financial accounts reports
Authors
- Colin Aaronson
- Content type: Miscellaneous
- Published: 01 October 2004
- Pages: 97 - 99